Stay updated on Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A sitewide NIH banner announcing a terminology transition from “Artificial Intelligence” to “Super Intelligence” was removed. The study record continues to display a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-08T13:59:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-11-01T15:22:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence.” It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T14:36:41.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T15:15:16.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:25:07.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the expected content and navigation. This indicates an access issue or site restriction affecting visibility of the study details.
    Difference
    21%
    Check dated 2026-09-20T20:21:55.000Z thumbnail image

Stay in the know with updates to Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.